U.S. Medical Oxygen Gas Cylinders Market Set to Reach ~USD 66.9 Million by 2031, Supported by Strong North America Demand | Key Players - Linde plc, Air Liquide, Taiyo Nippon Sanso

Leander Texas -
Medical Oxygen Gas Cylinders Market reached US$ 93.17 million in 2023 and is expected to reach US$ 264 million by 2031, growing at a CAGR of 10.16% during the forecast period 2024-2031.

The market's robust growth is fueled by rising respiratory care needs in the U.S., including new high-efficiency oxygen concentrators and collaborations in supply chain scaling, while in Japan, consolidation like the VitalAire Japan acquisition and expansion of distribution networks improve access and drive demand.

Download your exclusive sample report today: (corporate email gets priority access):https://www.datamintelligence.com/download-sample/medical-oxygen-gas-cylinders-market?prtk

Key Industry Development-

United States
✅ December 2025: Air Liquide expanded its medical oxygen cylinder production facility in Texas, incorporating smart IoT sensors for real-time pressure monitoring and leak detection to enhance safety in hospital and homecare settings.

✅ October 2025: Praxair (Linde) launched a lightweight composite medical oxygen cylinder with 20% weight reduction, targeting portable use for COPD patients amid rising respiratory cases.

✅ August 2025: Allied Healthcare Products introduced refillable aluminum oxygen cylinders with ergonomic valves, boosting homecare adoption through improved portability and regulatory compliance.

Asia Pacific / Japan
✅ November 2025: Tayama introduced eco-friendly medical oxygen cylinders using recycled composites in Japan, aligning with sustainability mandates and reducing carbon footprint for hospital supply chains.

✅ September 2025: Air Water Inc. launched high-capacity 50L steel oxygen cylinders with enhanced valve technology, supporting emergency response in aging populations with respiratory needs.

✅ July 2025: ME.BER. partnered with Japanese distributors to release portable oxygen cylinders featuring humidity control, catering to home healthcare growth in urban areas.

Strategic Mergers and Acquisitions:

In August 2025, French industrial gases leader Air Liquide S.A. agreed to acquire DIG Airgas, one of South Korea's largest industrial gas producers, from Macquarie Asia-Pacific Infrastructure Fund 2 for €2.85 billion (approximately US$3.3 billion). This deal is structured to bolster Air Liquide's footprint in the rapidly growing South Korean market and reinforce its global industrial and medical gas supply capabilities, with regulatory approvals anticipated to conclude in the first half of 2026.

Earlier in October 2025, Air Liquide also expanded its presence in the Indian industrial and medical gas sector through the acquisition of NovaAir, a key regional industrial gas producer and supplier in India. This strategic move strengthens the company's position across East and South India and enhances production and distribution capacities to meet rising demand from healthcare and other industrial segments.

Additionally, in May 2025, Air Liquide announced acquisitions in Germany of two outpatient intensive care service providers-intensivLeben GmbH and AP-Sachsen GmbH-to enhance its Home Healthcare business, which supports patients requiring chronic respiratory and related care services.

Major Players:-
AmcareMed Medical Gas System | Catalina Cylinders | Linde plc | AMS Composite Cylinders | Luxfer Gas Cylinders | Naugra Medical | Ultra Controlo International | Welz Gas Cylinder GmbH | SYC Cylinders | Faber Industrie SpA

Linde plc
A global industrial gas giant, Linde plc leads with extensive R&D, broad product portfolios (including medical oxygen solutions), and massive distribution networks. Its vertical integration-from gas production to cylinder delivery-ensures reliability, safety, and strong global reach, making it a go-to supplier for healthcare and industrial partners.

Catalina Cylinders
Catalina is a leading U.S. manufacturer of high-quality aluminum compressed gas cylinders, including medical oxygen tanks. Known for durable, lightweight designs and ISO-certified production, Catalina's strong presence in over 100 countries and long history in medical and specialty gases fuels its market leadership.

Luxfer Gas Cylinders
Luxfer is a top producer of high-pressure aluminum and composite cylinders used for medical oxygen and specialty gases. With millions of cylinders in use worldwide and continuous innovation in lightweight materials, it's widely trusted for safety, performance, and global availability across critical healthcare applications.

AMS Composite Cylinders
AMS Composite Cylinders specializes in advanced lightweight aluminium and carbon composite gas cylinders for global medical and healthcare use. Its focus on R&D delivers strong performance, lower weight, and customization, making it a preferred choice for portable medical oxygen and emergency response cylinders.

Faber Industrie S.p.A.
An Italian manufacturer of high-pressure steel and composite cylinders, Faber serves medical and industrial sectors globally. Known for robust engineering, wide cylinder capacity range, and quality certifications, its reliable products and international distribution help secure significant share in medical gas storage and delivery markets.

"Secure your 30% discount - get this report before the offer expires."
:https://www.datamintelligence.com/buy-now-page?report=medical-oxygen-gas-cylinders-market?prtk (Purchase 2 or more Repots and get 50% Discount)

Market Segmenatation-

Product Type: In both the United States and Japan, the market is segmented into portable and fixed/stationary oxygen gas cylinders, where portable cylinders-lightweight units designed for mobility and home-based use-have become increasingly prominent as demand rises for outpatient respiratory therapy, while fixed cylinders remain essential in hospitals and critical care units for reliable continuous oxygen delivery. In Japan specifically, fixed cylinders generated the largest share historically, though the portable segment is now the fastest growing as home oxygen therapy expands.

Material: The U.S. market further distinguishes cylinders by the material used, most commonly aluminum, steel, and increasingly carbon-fiber composites; aluminum holds a significant share due to its durability and lighter weight, while composite cylinders are gaining traction because they offer enhanced portability that meets the needs of aging populations and home healthcare users. In Japan, material preferences mirror these global trends with high quality standards driven by advanced manufacturing and safety regulations.

Cylinder Size/Capacity: Cylinder segmentation by capacity (e.g., smaller under 10 liters versus larger high-capacity units) matters especially in the U.S. as smaller, easier-to-handle sizes dominate homecare and emergency use, while larger sizes are more common in hospitals. Japanese segmentation also reflects similar capacity distinctions, with smaller cylinders preferred for personal use and larger fixed capacities installed in institutional settings.

Technology/Flow Type: The U.S. market segments cylinders by oxygen delivery technology (continuous flow versus pulse flow), with continuous flow systems widely used in clinical environments that require steady oxygen supply, and pulse flow gaining traction for ambulatory and home care due to efficiency in oxygen use. Japan's segmentation likewise recognizes these technological distinctions as part of broader medical device classifications that influence customer choice.

End-User: Both countries segment by end user-notably hospitals/clinics, home healthcare, and emergency services-with the U.S. seeing major volumes from hospitals and an expanding share in homecare due to chronic respiratory disease management, while in Japan the end-user segmentation reflects significant demand from healthcare facilities supported by an aging population and increasing home oxygen adoption.

Market Drivers:-

• Rising Prevalence of Respiratory Disorders and Aging Population: In the United States, increasing COPD and asthma cases, along with a rapidly aging demographic, are driving long-term oxygen therapy demand. In Japan, one of the world's oldest populations and high incidence of chronic respiratory failure significantly accelerate medical oxygen cylinder utilization in hospitals and homecare settings.

• Expansion of Home Healthcare and Long-Term Oxygen Therapy (LTOT): The U.S. Centers for Medicare & Medicaid Services reimbursement framework supports home oxygen therapy, boosting cylinder adoption for domiciliary use. In Japan, national health insurance coverage for home oxygen therapy has expanded patient access, encouraging portable and refillable oxygen cylinder deployment.

• Emergency Preparedness and Strategic Stockpiling Initiatives: Following COVID-19 supply disruptions, the U.S. government strengthened the Strategic National Stockpile to secure medical oxygen reserves. Similarly, Japan's Ministry of Health, Labour and Welfare reinforced domestic oxygen production and cylinder storage systems to enhance disaster and pandemic readiness.

• Technological Advancements and Safety Compliance Standards: U.S. manufacturers are investing in lightweight aluminum and composite cylinders with enhanced pressure regulation systems to meet FDA and DOT standards. In Japan, strict high-pressure gas safety regulations are prompting innovation in compact, high-durability cylinders suitable for hospital and home environments.

• Industry Partnerships and Capacity Expansion Announcements: In the U.S., major gas suppliers such as Air Products and Chemicals and Linde plc have expanded medical oxygen production capacity post-pandemic. In Japan, companies including Taiyo Nippon Sanso have announced infrastructure upgrades and healthcare collaborations to strengthen medical oxygen distribution networks.

Regional insights:-

North America: 36.2% (Largest share, driven by robust healthcare infrastructure and high adoption of oxygen therapy; the United States alone accounts for 19.6% of the global market due to advanced healthcare spending and chronic disease prevalence)

Asia Pacific: 27.8% (Second largest, fastest-growing region; growth fueled by expanding healthcare services, strong demand in China, Japan contributing a notable share within APAC, and increasing respiratory disease burden)

Europe: 26.5% (Steady share backed by established healthcare systems and consistent demand for oxygen delivery in hospitals and clinics)

Get Customization in the report as per your requirements:https://www.datamintelligence.com/customize/medical-oxygen-gas-cylinders-market?prtk

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?pratik
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About DataM Intelligence
DataM Intelligence is a renowned provider of market research, delivering deep insightsthrough pricing analysis, market share breakdowns, and competitive intelligence. Thecompany specializes in strategic reports that guide businesses in high-growth sectors suchas nutraceuticals and AI-driven health innovations.
To find out more, visit https://www.datamintelligence.com/ or follow us on Twitter,LinkedIn and Facebook.

This release was published on openPR.